Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin E cost-effectiveness

This article was originally published in The Tan Sheet

Executive Summary

Researchers at the Medical Technology Assessment Group and the University of Sydney, Australia found a cost savings of $578 per patient in the U.S. and $181 per patient in Australia in coronary heart disease patients taking vitamin E supplements, according to a study published in the Aug. 15 American Journal of Cardiology. The majority of the savings were due to a reduction in hospital admissions for nonfatal heart attacks. Costs saved were related to bed stays, procedures and medication. The researchers based their estimates on published data from the Cambridge Heart Antioxidant Study (CHAOS), published in 1996. The study of 2,002 patients found vitamin E reduced non-fatal heart attack risk by 77%
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088988

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel